Outpatient Facility Coding Alert - 2004 Issue 19
Labs: Blood Test Panels Now Under The OIG's Microscope
Subscribe or sign in to view the full article.
Article Overview
This article discusses a civil settlement involving a clinical laboratory accused of altering blood test panels and billing public programs for additional testing. It is relevant to laboratory compliance teams, billing professionals, auditors, and healthcare attorneys who monitor fraud and abuse risk in diagnostic testing claims. The piece focuses on whistleblower activity, False Claims Act exposure, and the compliance significance of reviewing commonly ordered lab panels.
Why This Topic Matters
It highlights how lab billing practices tied to blood test panels can trigger fraud investigations and substantial financial penalties when medically unnecessary components are alleged.
What You Will Learn
- How blood test panel billing can create compliance risk
- Why medically unnecessary tests in a panel can attract scrutiny
- How whistleblower actions can lead to civil settlement exposure
- What kinds of organizations and payers may be implicated in lab claim reviews
Who Should Read This
- Clinical laboratories
- Medical billing and coding professionals
- Compliance officers
- Healthcare auditors
- Healthcare attorneys
- Revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com